No Detail Found!

HPLC determination of entecavir in pure, tablet dosage form and spiked plasma.

Author(s)
Muhammad Ashraf Department of Chemistry, The Islamia University of Bahawalpur,Bahawalpur,
Hafiz Muhammad Nauman Shabbir Department of Pharmacy, The Islamia University of Bahawalpur,Bahawalpur,Pakistan
Muhammad Munawar Hayat Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Jameel Rahman Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
Samina Ejaz Department of Biochemistry & Biotechnology, The Islamia University of Bahawalpur,Bahawalpur,Pakistan
Muhammad Iqbal Department of Biochemistry & Biotechnology, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
Faiz-ul-Hassan Nasim Department of Chemistry, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
Abstract
Summary: Entecavir is an analogue with selective activity against hepatitis B virus. In this study, an HPLC method for the determination of entecavir was developed. Entecavir was eluted through C18 ODS Hypersil column of 150 × 4.6 mm id with 5 µm particle size using simple mobile phase of acetonitrile: 10 mM phosphate buffer (80:20) at a flow rate of 1.0 mL min-1 and eluate was detected at 218 nm. Etoposide was used as an internal standard. The accuracy of the developed method was 97-99% for both with-in-batch and between-batches studies and CV (%) of < 3. The new method is highly sensitive upto 0.0097 µg mL-1. The validation results and statistical data demonstrate that the method is more sensitive, reliable and reproducible and has an importance in quality assurance of entecavir analysis and in bioequivalence studies.
Publication Details
Page(s) 1-5
DOI DOI not available
Published Journal: Journal of Chemical Society of Pakistan, Volume: 39, Issue: 1, Year: 2017

Request the full text from PASTIC

Keywords
HPLC, tablet dosage form, etoposide, Entecavir
0

Citations

0

Downloads

40

Views